Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228885/ https://www.ncbi.nlm.nih.gov/pubmed/34792132 http://dx.doi.org/10.1093/ecco-jcc/jjab207 |
_version_ | 1784734592663552000 |
---|---|
author | Bacsur, Péter Farkas, Klaudia Molnar, Tamás |
author_facet | Bacsur, Péter Farkas, Klaudia Molnar, Tamás |
author_sort | Bacsur, Péter |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9228885 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-92288852022-06-28 Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients Bacsur, Péter Farkas, Klaudia Molnar, Tamás J Crohns Colitis Letters to the Editor Oxford University Press 2021-11-18 /pmc/articles/PMC9228885/ /pubmed/34792132 http://dx.doi.org/10.1093/ecco-jcc/jjab207 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letters to the Editor Bacsur, Péter Farkas, Klaudia Molnar, Tamás Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients |
title | Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients |
title_full | Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients |
title_fullStr | Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients |
title_full_unstemmed | Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients |
title_short | Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients |
title_sort | outcome of immediate dose optimization of infliximab in inflammatory bowel disease patients |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228885/ https://www.ncbi.nlm.nih.gov/pubmed/34792132 http://dx.doi.org/10.1093/ecco-jcc/jjab207 |
work_keys_str_mv | AT bacsurpeter outcomeofimmediatedoseoptimizationofinfliximabininflammatoryboweldiseasepatients AT farkasklaudia outcomeofimmediatedoseoptimizationofinfliximabininflammatoryboweldiseasepatients AT molnartamas outcomeofimmediatedoseoptimizationofinfliximabininflammatoryboweldiseasepatients |